Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001829126-25-008213
Filing Date
2025-10-17
Accepted
2025-10-17 17:29:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10047
2 EXHIBIT 99.1 novabay_ex99-1.htm EX-99.1 131320
  Complete submission text file 0001829126-25-008213.txt   142888
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 251401663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44, TOWER 100, THE TOWERS WINSTON CHURCHILL, PAITILLA PANAMA CITY Panama
Business Address
Lazar David E. (Filed by) CIK: 0001932843 (see all company filings)

Type: SCHEDULE 13D/A